Increases in oxidative stress levels and inflammatory markers, LH and androgens, and a significant reduction in follicle stimulating hormone (FSH) and estrogen have been reported in patients with PCOS and also in animal models of PCOS (7, 8). This evidence concerns the gene BRD2 and polycystic ovary syndrome.